NGS Technology in Monitoring the Genetic Diversity of Cytomegalovirus Strains.

IF 1.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
Sovremennye Tehnologii v Medicine Pub Date : 2023-01-01 Epub Date: 2023-03-29 DOI:10.17691/stm2023.15.2.04
O E Vankova, N F Brusnigina, N A Novikova
{"title":"NGS Technology in Monitoring the Genetic Diversity of Cytomegalovirus Strains.","authors":"O E Vankova, N F Brusnigina, N A Novikova","doi":"10.17691/stm2023.15.2.04","DOIUrl":null,"url":null,"abstract":"<p><p>Modern molecular genetic methods, massive parallel sequencing in particular, allow for genotyping of various pathogens with the aim of their epidemiological marking and improvement of molecular epidemiological surveillance of actual infections, including cytomegalovirus infection. <b>The aim of the study</b> is to evaluate the next-generation sequencing (NGS) technology for genotyping clinical isolates of cytomegalovirus (CMV).</p><p><strong>Materials and methods: </strong>The object of the study were samples of biological substrates (leukocyte mass, saliva, urine) taken from patients who underwent liver and kidney transplantation. Detection of CMV DNA was carried out by a real-time PCR using commercial diagnostic AmpliSense CMV-FL test systems (Central Research Institute for Epidemiology, Moscow, Russia). DNA extraction was performed using DNA-sorb AM and DNA-sorb V kits (Central Research Institute for Epidemiology) in accordance with manufacturer's manual. The quality of the prepared DNA library for sequencing was assessed by means of the QIAxcel Advanced System capillary gel electrophoresis system (QIAGEN, Germany). Alignment and assembly of nucleotide sequences were carried out using CLC Genomics Workbench 5.5 software (CLC bio, USA). The sequencing results were analyzed using BLAST of NCBI server.</p><p><strong>Results: </strong>CMV DNA samples were selected for genotyping. The two variable genes, <i>UL55</i>(gB) and <i>UL73</i>(gN), were used for CMV genotype determination, which was performed using NGS technology MiSeq sequencer (Illumina, USA). Based on the exploratory studies and analysis of literature sources, primers for genotyping on the <i>UL55</i>(gB) and <i>UL73</i>(gN) genes have been selected and the optimal conditions for the PCR reaction have been defined. The results of sequencing the <i>UL55</i>(gB) and <i>UL73</i>(gN) gene fragments of CMV clinical isolates from recipients of solid organs made it possible to determine the virus genotypes, among which gB2, gN4c, and gN4b were dominant. In some cases, association of two and three CMV genotypes has been revealed.</p><p><strong>Conclusion: </strong>The application of the NGS technology for genotyping cytomegalovirus strains can become one of the main methods of CMV infection molecular epidemiology, as it allows for obtaining reliable results with a significant reduction in research time.</p>","PeriodicalId":51886,"journal":{"name":"Sovremennye Tehnologii v Medicine","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306971/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sovremennye Tehnologii v Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17691/stm2023.15.2.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/3/29 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Modern molecular genetic methods, massive parallel sequencing in particular, allow for genotyping of various pathogens with the aim of their epidemiological marking and improvement of molecular epidemiological surveillance of actual infections, including cytomegalovirus infection. The aim of the study is to evaluate the next-generation sequencing (NGS) technology for genotyping clinical isolates of cytomegalovirus (CMV).

Materials and methods: The object of the study were samples of biological substrates (leukocyte mass, saliva, urine) taken from patients who underwent liver and kidney transplantation. Detection of CMV DNA was carried out by a real-time PCR using commercial diagnostic AmpliSense CMV-FL test systems (Central Research Institute for Epidemiology, Moscow, Russia). DNA extraction was performed using DNA-sorb AM and DNA-sorb V kits (Central Research Institute for Epidemiology) in accordance with manufacturer's manual. The quality of the prepared DNA library for sequencing was assessed by means of the QIAxcel Advanced System capillary gel electrophoresis system (QIAGEN, Germany). Alignment and assembly of nucleotide sequences were carried out using CLC Genomics Workbench 5.5 software (CLC bio, USA). The sequencing results were analyzed using BLAST of NCBI server.

Results: CMV DNA samples were selected for genotyping. The two variable genes, UL55(gB) and UL73(gN), were used for CMV genotype determination, which was performed using NGS technology MiSeq sequencer (Illumina, USA). Based on the exploratory studies and analysis of literature sources, primers for genotyping on the UL55(gB) and UL73(gN) genes have been selected and the optimal conditions for the PCR reaction have been defined. The results of sequencing the UL55(gB) and UL73(gN) gene fragments of CMV clinical isolates from recipients of solid organs made it possible to determine the virus genotypes, among which gB2, gN4c, and gN4b were dominant. In some cases, association of two and three CMV genotypes has been revealed.

Conclusion: The application of the NGS technology for genotyping cytomegalovirus strains can become one of the main methods of CMV infection molecular epidemiology, as it allows for obtaining reliable results with a significant reduction in research time.

Abstract Image

Abstract Image

用 NGS 技术监测巨细胞病毒株的基因多样性。
现代分子遗传学方法,尤其是大规模并行测序技术,可以对各种病原体进行基因分型,从而对其进行流行病学标记,并改进对实际感染(包括巨细胞病毒感染)的分子流行病学监测。本研究旨在评估用于巨细胞病毒(CMV)临床分离株基因分型的新一代测序(NGS)技术:研究对象是肝肾移植患者的生物基质样本(白细胞质量、唾液、尿液)。使用商业诊断 AmpliSense CMV-FL 检测系统(俄罗斯莫斯科,流行病学中央研究所)进行实时 PCR 检测 CMV DNA。DNA 提取使用 DNA-sorb AM 和 DNA-sorb V 试剂盒(流行病学中央研究所),按照制造商手册进行。用 QIAxcel Advanced System 毛细管凝胶电泳系统(QIAGEN,德国)对所制备的测序 DNA 文库的质量进行评估。核苷酸序列的比对和组装使用 CLC Genomics Workbench 5.5 软件(CLC bio,美国)进行。测序结果使用 NCBI 服务器的 BLAST 进行分析:选择 CMV DNA 样品进行基因分型。利用 NGS 技术 MiSeq 测序仪(Illumina,美国)对两个可变基因 UL55(gB) 和 UL73(gN) 进行了 CMV 基因型鉴定。根据探索性研究和对文献资料的分析,选择了对 UL55(gB) 和 UL73(gN) 基因进行基因分型的引物,并确定了 PCR 反应的最佳条件。对来自实体器官受体的 CMV 临床分离株的 UL55(gB)和 UL73(gN) 基因片段进行测序的结果可以确定病毒的基因型,其中以 gB2、gN4c 和 gN4b 型为主。在某些病例中,还发现了两种和三种 CMV 基因型的关联:结论:应用 NGS 技术对巨细胞病毒株进行基因分型可成为巨细胞病毒感染分子流行病学研究的主要方法之一,因为它能在显著缩短研究时间的同时获得可靠的结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Sovremennye Tehnologii v Medicine
Sovremennye Tehnologii v Medicine MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
1.80
自引率
0.00%
发文量
38
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信